We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





How Mentoring Connections Can Make All the Difference

By Jen A. Miller (AACC)
Posted on 07 Jul 2023
The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be a destination for clinical laboratorians and those interested in the field from all walks of life, including young professionals. More...
For this group, AACC has included two key events: the Society for Young Clinical Laboratorians (SYCL) Workshop and Mixer on Saturday, and the Careers in Industry 2023: Impact Patient Care through Industry luncheon and panel discussion on Sunday.

Both of these events are designed to help early career professionals find their footing, including those who are new to the field and curious about different approaches to their career opportunities.

The Careers in Industry event, hosted by AACC’s Corporate Advisory Board (CAB) and SYCL, “offers different pathways for laboratorians in all disciplines and degrees to support healthcare, even if it’s not directly inside of a hospital,” said LaShanta Brice, DCLS, MLS (ASCP)SH, scientific engagement and clinical education associate at Stago, and who was a panelist during last year’s Careers in Industry luncheon. The event features leaders working at top diagnostic companies with diverse sets of backgrounds sharing their career paths, expertise, and experiences, followed by a Q&A portion and time for networking.

The Careers in Industry panelists will be a mix of beginning, middle, and advanced career laboratorians, which means young attendees coming to this interactive session will get a “good mix of professionals so you can see a pathway in front of you,” she added.

Brice earned a clinical doctorate in clinical laboratory science which she said is a fairly new degree. The path ahead of her was less clear than if she’d taken a more traditional laboratory medicine route. “One of the challenges was trying to find a group of people that I could talk to, and who could potentially be my advisors outside of the hospital,” she said. She found that both SYCL and the CAB were “great places for me to get connected” with the industry side of laboratory medicine.

For 10 years, including the time she worked on her doctorate degree, she worked at the Brook Army Medical Center, starting as a lead hematology medical laboratory scientist and rising to hematology supervisor. There, she was given a military coin from the chief of medicine—a rare honor for a civilian, and a career highlight, she said.

Looking for a new challenge, and with a doctoral degree in hand, she moved to Stago, and into project management. The connections she made, and mentorship she found, at AACC have helped her make the transition from the bench into scientific affairs and project management. It wasn’t easy at first. “I was so used to firefighting that I didn’t land very well with long term projects. I tended to finish projects like I was Sonic the Hedgehog,” she joked.

But AACC helped. “Now I have to make connections to different groups outside of the laboratory as opposed to working on issues within four walls,” she said. Through mentorships, she learned she didn’t need to rush all the time, and to slow down. In doing so, she has been able to focus on working outside the laboratory with multiple sets of clinicians.

Brice is looking forward to meeting new young professionals at the meeting this year and helping them make the same links, especially for those interested in industry work. “SYCL is the best way for you to connect with AACC if you’re looking to dip your toes into the water and find someone you can partner with as you journey through the process,” she said.

SYCL can also help first time attendees navigate a conference that has returned to full, in-person size since the COVID-19 pandemic. “If this is your first time to AACC, it’s quite overwhelming. The expo floor is gigantic. There are so many scientific sessions, and it can feel daunting if you don’t have a way to find out information and connect with people that are like minded,” she said.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.